0001104659-21-102945 Sample Contracts

Marker Therapeutics, Inc., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 20__ Debt Securities
Indenture • August 10th, 2021 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York

Indenture, dated as of [·], 20__, among Marker Therapeutics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):

AutoNDA by SimpleDocs
Marker Therapeutics, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • August 10th, 2021 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York

Marker Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. and RBC Capital Markets, LLC (each, an “Agent,” and together, the “Agents”), as follows:

Marker Therapeutics, Inc. and _____________, As Warrant Agent Form of Common Stock Warrant Agreement Dated As Of __________
Common Stock Warrant Agreement • August 10th, 2021 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York

This Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between Marker Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Marker Therapeutics, Inc. and _____________, As Warrant Agent Form of Preferred Stock Warrant Agreement Dated As Of __________
Preferred Stock Warrant Agreement • August 10th, 2021 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York

This Preferred Stock Warrant Agreement (this “Agreement”), dated as of [●], between Marker Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Marker Therapeutics, Inc. and _____________, As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of __________
Debt Securities Warrant Agreement • August 10th, 2021 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York

This Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Marker Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Time is Money Join Law Insider Premium to draft better contracts faster.